A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose

Updated 06/21/2024

Status Completed

Clinical Trial Summary

This is a randomized, double-blind, placebo controlled, single ascending dose escalation, safety, tolerability, PK, PD and immunogenicity study of BMS-986168 administered by an intravenous infusion in healthy subjects.

Clinical Trial Description

This study, previously posted by Bristol-Myers Squibb, has transitioned to Biogen under a licensing agreement. ;

Study Design

Related Conditions & MeSH terms

Tauopathies

Clinical Trial Details

NCT number	NCT02294851
Study type	Interventional
Source	Biogen
Contact
Status	Completed
Phase	Phase 1
Start date	December 31, 2014
Completion date	April 30, 2016

See also
	Status	Clinical Trial	Phase
	Completed	`NCT05080777` - Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems	N/A
	Completed	`NCT03538522` - A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831	Phase 2
	Recruiting	`NCT05508789` - A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)	Phase 3
	Recruiting	`NCT05427448` - Validation of Blood Biomarkers for Alzheimer's Disease	N/A
	Active, not recruiting	`NCT05344989` - A First-in-Human Study to Assess Single Doses of APNmAb005 in Healthy Participants	Phase 1
	Recruiting	`NCT01696591` - The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD	N/A
	Withdrawn	`NCT05321498` - Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation	Phase 2
	Completed	`NCT04445831` - A Study to Evaluate the Safety, Tolerability and Immunogenicity of Tau Targeted Vaccines in Participants With Early Alzheimer's Disease	Phase 1/Phase 2
	Recruiting	`NCT06083467` - CW2IP2: Imaging and Diagnostic Assessments	Early Phase 1
	Completed	`NCT05527288` - A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population	N/A
	Completed	`NCT02860338` - COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE	N/A
	Completed	`NCT05202223` - Harmony at Home: A Pilot Telehealth Program for Rural ADRD Caregivers	N/A
	Recruiting	`NCT05318976` - A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation	Phase 2
	Active, not recruiting	`NCT05522387` - An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease	Phase 2
	Completed	`NCT02103894` - Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects	Phase 1
	Recruiting	`NCT06303921` - Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503	Early Phase 1
	Recruiting	`NCT06032026` - Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15	Early Phase 1
	Completed	`NCT03938870` - CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease
	Completed	`NCT02676843` - Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations	Phase 2